Medical Devices Singapore

Singapore Genetic Testing Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Singapore Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Type, Technology, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $26.3 Mn Placeholder estimate
Estimate 2025 $29.3 Mn 0.1% of the global market
Projected 2034 $77.4 Mn 164.2% Adds $48.1 Mn over 9 forecast years
CAGR 2025–2034 11.4% Faster than 68% of 193 Medical Devices markets here
Key players 6 +1
  • Singapore is 0.13% of the global market.
  • In APAC, the largest is China at $1.95 Bn.
  • Fastest growing: India at 13.6% a year.
  • Singapore ranks 13th of 14 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$48.1 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Genetic Testing Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $26.3 Mn — —
2025 (base) $29.3 Mn +$3.0 Mn —
2026 (forecast) $32.6 Mn +$3.3 Mn +11.4%
2027 (forecast) $36.3 Mn +$3.7 Mn +24.1%
2028 (forecast) $40.5 Mn +$4.1 Mn +38.2%
2029 (forecast) $45.1 Mn +$4.6 Mn +54%
2030 (forecast) $50.2 Mn +$5.1 Mn +71.6%
2031 (forecast) $56.0 Mn +$5.7 Mn +91.1%
2032 (forecast) $62.4 Mn +$6.4 Mn +112.9%
2033 (forecast) $69.5 Mn +$7.1 Mn +137.2%
2034 (forecast) $77.4 Mn +$7.9 Mn +164.2%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Singapore Genetic Testing Market Analysis at a glance
Market size, 2025$29.3 Mn placeholder estimate
Forecast, 2034$77.4 Mn placeholder estimate
Growth (CAGR), 2025–203411.4% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, technology and end user (see all)
Key playersMyriad Genetics, Inc., Illumina, Inc., Natera, Invitae, Quest Diagnostics and 1 more (see all)
Regulator in SingaporeHSASource: Health Sciences Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore Genetic Testing Market Analysis Executive Summary

Genetic testing reads a person's DNA to find inherited conditions, cancer risk, drug response and family links.

Key segments of the genetic testing market include type (Predictive Testing, Carrier Testing and Diagnostic Testing) and technology (PCR, Sequencing and Microarrays).

Bar chart: Singapore Genetic Testing market size, 2024–2034, placeholder estimates. $26.3 Mn in 2024, $29.3 Mn in 2025 and $77.4 Mn in 2034, 11.4% CAGR.
Singapore Genetic Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore Genetic Testing Market Dynamics

Market Growth Drivers

Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the genetic testing market.

Opportunity

Automation, smaller and cheaper instruments and growth in cancer and genetic testing give the genetic testing market room to grow.

Market Restraints

Costly instruments, a shortage of skilled lab staff and uneven payment for new tests hold back the genetic testing market.

Competitive Landscape for Genetic Testing Market in Singapore

The genetic testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Genetic Testing Market in Singapore

Genetic Testing in Singapore: rules and payment

Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices.⁠[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[2]

[1] Health Sciences Authority. Checked 14 Nov 2026.

[2] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how genetic testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Genetic Testing right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Genetic Testing in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 17 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 8th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 22 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 21 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Genetic Testing market in Singapore?
Placeholder estimate: about $29.3 Mn in 2025, rising to about $77.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Genetic Testing market in Singapore growing?
Placeholder estimate: about 11.4% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Genetic Testing market report cover?
The report splits the market by type (Predictive Testing, Carrier Testing, Diagnostic Testing, Newborn Screening and more), technology (PCR, Sequencing, Microarrays) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Genetic Testing market?
Key players include Myriad Genetics, Inc., Illumina, Inc., Natera, Invitae, Quest Diagnostics and Labcorp.
What is driving the Genetic Testing market?
Falling costs of testing, more demand for precision medicine and steady research spending by drug makers and labs are driving the genetic testing market.
Who regulates Genetic Testing in Singapore?
Medical devices must be registered with the Health Sciences Authority (HSA), except low-risk Class A devices. Source: Health Sciences Authority. Checked 14 Nov 2026.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Singapore

See all

Related on genomics and diagnostics and lab testing

See the topic